These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36607843)

  • 1. Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: A retrospective single-centre analysis from a German high-volume centre.
    Winkler T; von Klot CAJ; Madersbacher S; Kuczyk MA; Wolters M
    PLoS One; 2023; 18(1):e0279883. PubMed ID: 36607843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
    Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rezūm for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia.
    Bassily D; Wong V; Phillips JL; Fraiman M; Bauer R; Dixon CM; Wong NC
    Prostate; 2021 Oct; 81(14):1049-1054. PubMed ID: 34287992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study.
    Wolters M; Krastel M; Winkler T; Idais H; Mazdak M; Tezval H; Kuczyk MA; von Klot CJ
    Prostate Cancer Prostatic Dis; 2024 Apr; ():. PubMed ID: 38658736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis.
    Haroon UM; Khan JS; McNicholas D; Forde JC; Davis NF; Power RE
    Ir J Med Sci; 2022 Feb; 191(1):421-426. PubMed ID: 33599918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world evidence with The Rezūm System: A retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes.
    Ines M; Babar M; Singh S; Iqbal N; Ciatto M
    Prostate; 2021 Sep; 81(13):956-970. PubMed ID: 34254333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
    Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients.
    Bausch K; Zahiti L; Schrutt M; Wetterauer C; Halbeisen FS; Ebbing J; Seifert HH
    World J Urol; 2023 Jun; 41(6):1605-1612. PubMed ID: 37140664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot Study of "Less is More" Rezum for Treatment of BPH.
    Aladesuru O; Amankwah K; Elterman D; Zorn KC; Bhojani N; Te A; Chughtai B
    Urology; 2022 Jul; 165():256-260. PubMed ID: 35139413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rezūm water vapor thermal therapy in patients with benign prostatic hyperplasia: Initial real-world data from Japan.
    Obinata D; Mochida J; Uehara R; Osawa M; Hashimoto S; Nakahara K; Yoshizawa T; Yamaguchi K; Takahashi S
    Medicine (Baltimore); 2023 Nov; 102(46):e36055. PubMed ID: 37986385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review.
    Babar M; Loloi J; Tang K; Syed U; Ciatto M
    Low Urin Tract Symptoms; 2022 May; 14(3):140-154. PubMed ID: 35233955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One hundred cases of Rezum water vapor thermal therapy for benign prostatic hyperplasia: Real-world data at a single institution in Japan.
    Haga K; Akagashi K; Tobe M; Uchida K; Honma I; Hirobe E; Ishizaki J; Shimizu T; Nakajima H; Urahama S; Sato Y
    Int J Urol; 2024 Dec; 31(12):1337-1342. PubMed ID: 39187956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia?
    McVary KT; Rogers T; Mahon J; Gupta NK
    J Sex Med; 2018 Dec; 15(12):1728-1738. PubMed ID: 30446471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Is New with Rezūm Water Vapor Thermal Therapy for LUTS/BPH?
    Doppalapudi SK; Gupta N
    Curr Urol Rep; 2021 Jan; 22(1):4. PubMed ID: 33403529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.
    Elterman D; Shepherd S; Saadat SH; Alshak MN; Bhojani N; Zorn KC; Rijo E; Misrai V; Lajkosz K; Chughtai B
    Can J Urol; 2021 Oct; 28(5):10824-10833. PubMed ID: 34657655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term Outcomes of Water Vapor Therapy (Rezūm) for BPH/LUTS in the First Czech Cohort.
    Wasserbauer R; Pacik D; Varga G; Vit V; Jarkovsky J; Fedorko M
    Urol J; 2021 Sep; 18(6):699-702. PubMed ID: 34549803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year.
    Alegorides C; Fourmarier M; Eghazarian C; Lebdai S; Chevrot A; Droupy S
    Prog Urol; 2020 Oct; 30(12):624-631. PubMed ID: 32826195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Darson MF; Alexander EE; Schiffman ZJ; Lewitton M; Light RA; Sutton MA; Delgado-Rodriguez C; Gonzalez RR
    Res Rep Urol; 2017; 9():159-168. PubMed ID: 28861405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Rezum therapy as a minimally invasive modality for management of Benign Prostatic Hyperplasia: A prospective observational study.
    Abouelgreed TA; Koritenah AK; Badran Y; Tagreda I; Algammal M; Abozied H; Eldamanhory HA; Shouman HA; Khattab AA; Ali M; Alnajem MT; Abdelwahed AA
    Arch Ital Urol Androl; 2023 Dec; 95(4):12026. PubMed ID: 38193224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study.
    Siena G; Cindolo L; Ferrari G; Maruzzi D; Fasolis G; Condorelli SV; Varvello F; Visalli F; Rabito S; Toso S; Caroassai S; Mari A; Viola L; Somani BK; Carini M
    World J Urol; 2021 Oct; 39(10):3875-3880. PubMed ID: 33787986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.